This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...

Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that results from the Phase III ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, ...

Kubota, C. (2025) The Utility of Offering Course Subjects on Family Support for Paramedics in an Undergraduate Curriculum.

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...

VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / North Shore Uranium Ltd. (TSXV:NSU) (“North Shore” or the “Company“) is pleased to announce the completion of a prospecting program on its Falcon ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.

AlphaTON Capital Corp ( Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today announced that a new poster is live at the AACR ...